Prestige Consumer Healthcare (PBH) Enterprise Value (2010 - 2025)

Prestige Consumer Healthcare's Enterprise Value history runs 16 years deep, the most recent figure standing at -$62.4 million for Q4 2025.

• On a quarterly basis, Enterprise Value fell 22.6% year-over-year to -$62.4 million in Q4 2025; TTM through Dec 2025 was -$62.4 million, a 22.6% decrease from a year earlier, with the FY2025 full-year figure at -$97.9 million, down 110.64% from the prior year.
• Enterprise Value rose to -$62.4 million in Q4 2025 per PBH's latest filing, from -$119.1 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$21.0 million in Q4 2021 and bottomed at -$163.6 million in Q2 2021.
• The 5-year median for Enterprise Value is -$53.1 million (2023), against an average of -$64.5 million.
• Biggest YoY gain for Enterprise Value was 78.08% in 2022; the steepest drop was 310.88% in 2022.
• Year by year, Enterprise Value stood at -$21.0 million in 2021, then slumped by 310.88% to -$86.4 million in 2022, then climbed by 26.34% to -$63.6 million in 2023, then rose by 20.03% to -$50.9 million in 2024, then fell by 22.6% to -$62.4 million in 2025.
• Per Business Quant, the three latest PBH Enterprise Value figures stand at -$62.4 million (Q4 2025), -$119.1 million (Q3 2025), and -$139.5 million (Q2 2025).